nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Clotting—Temozolomide—malignant glioma	0.0425	0.0444	CcSEcCtD
Perflutren—Sevoflurane—CYP2B6—malignant glioma	0.0421	1	CrCbGaD
Perflutren—Transient ischaemic attack—Temozolomide—malignant glioma	0.0301	0.0314	CcSEcCtD
Perflutren—Burning sensation—Carmustine—malignant glioma	0.0226	0.0236	CcSEcCtD
Perflutren—Influenza-like symptoms—Temozolomide—malignant glioma	0.0213	0.0222	CcSEcCtD
Perflutren—Coagulopathy—Temozolomide—malignant glioma	0.0195	0.0204	CcSEcCtD
Perflutren—Injection site pain—Carmustine—malignant glioma	0.0193	0.0201	CcSEcCtD
Perflutren—Rigors—Temozolomide—malignant glioma	0.0186	0.0194	CcSEcCtD
Perflutren—Leukocytosis—Carmustine—malignant glioma	0.0167	0.0175	CcSEcCtD
Perflutren—Hearing impaired—Temozolomide—malignant glioma	0.016	0.0167	CcSEcCtD
Perflutren—Neck pain—Carmustine—malignant glioma	0.0159	0.0166	CcSEcCtD
Perflutren—Injection site reaction—Carmustine—malignant glioma	0.0156	0.0163	CcSEcCtD
Perflutren—Musculoskeletal pain—Temozolomide—malignant glioma	0.0154	0.016	CcSEcCtD
Perflutren—Influenza like illness—Temozolomide—malignant glioma	0.0148	0.0154	CcSEcCtD
Perflutren—Coma—Carmustine—malignant glioma	0.0144	0.015	CcSEcCtD
Perflutren—Abnormal vision—Carmustine—malignant glioma	0.0137	0.0143	CcSEcCtD
Perflutren—Abnormal vision—Temozolomide—malignant glioma	0.0132	0.0138	CcSEcCtD
Perflutren—Swelling—Carmustine—malignant glioma	0.0129	0.0135	CcSEcCtD
Perflutren—Hot flush—Temozolomide—malignant glioma	0.0118	0.0123	CcSEcCtD
Perflutren—Menopausal symptoms—Temozolomide—malignant glioma	0.0117	0.0122	CcSEcCtD
Perflutren—Face oedema—Carmustine—malignant glioma	0.011	0.0115	CcSEcCtD
Perflutren—Face oedema—Temozolomide—malignant glioma	0.0106	0.0111	CcSEcCtD
Perflutren—Dry skin—Temozolomide—malignant glioma	0.0101	0.0106	CcSEcCtD
Perflutren—Sweating increased—Temozolomide—malignant glioma	0.00928	0.00969	CcSEcCtD
Perflutren—Neuropathy peripheral—Carmustine—malignant glioma	0.00862	0.009	CcSEcCtD
Perflutren—Neuropathy peripheral—Temozolomide—malignant glioma	0.00833	0.00869	CcSEcCtD
Perflutren—Haemoglobin—Carmustine—malignant glioma	0.00793	0.00828	CcSEcCtD
Perflutren—Haemorrhage—Carmustine—malignant glioma	0.00789	0.00824	CcSEcCtD
Perflutren—Hypoaesthesia—Carmustine—malignant glioma	0.00785	0.0082	CcSEcCtD
Perflutren—Connective tissue disorder—Carmustine—malignant glioma	0.00776	0.0081	CcSEcCtD
Perflutren—Haemoglobin—Temozolomide—malignant glioma	0.00767	0.008	CcSEcCtD
Perflutren—Haemorrhage—Temozolomide—malignant glioma	0.00763	0.00796	CcSEcCtD
Perflutren—Visual impairment—Carmustine—malignant glioma	0.00761	0.00794	CcSEcCtD
Perflutren—Hypoaesthesia—Temozolomide—malignant glioma	0.00759	0.00792	CcSEcCtD
Perflutren—Pharyngitis—Temozolomide—malignant glioma	0.00757	0.0079	CcSEcCtD
Perflutren—Connective tissue disorder—Temozolomide—malignant glioma	0.0075	0.00782	CcSEcCtD
Perflutren—Eye disorder—Carmustine—malignant glioma	0.00738	0.0077	CcSEcCtD
Perflutren—Visual impairment—Temozolomide—malignant glioma	0.00735	0.00767	CcSEcCtD
Perflutren—Flushing—Carmustine—malignant glioma	0.00733	0.00765	CcSEcCtD
Perflutren—Eye disorder—Temozolomide—malignant glioma	0.00713	0.00744	CcSEcCtD
Perflutren—Tinnitus—Temozolomide—malignant glioma	0.00711	0.00742	CcSEcCtD
Perflutren—Cardiac disorder—Temozolomide—malignant glioma	0.00708	0.00739	CcSEcCtD
Perflutren—Flushing—Temozolomide—malignant glioma	0.00708	0.00739	CcSEcCtD
Perflutren—Arrhythmia—Carmustine—malignant glioma	0.00705	0.00736	CcSEcCtD
Perflutren—Angiopathy—Temozolomide—malignant glioma	0.00692	0.00722	CcSEcCtD
Perflutren—Immune system disorder—Temozolomide—malignant glioma	0.00689	0.00719	CcSEcCtD
Perflutren—Mediastinal disorder—Temozolomide—malignant glioma	0.00687	0.00718	CcSEcCtD
Perflutren—Erythema—Carmustine—malignant glioma	0.00687	0.00717	CcSEcCtD
Perflutren—Chills—Temozolomide—malignant glioma	0.00684	0.00714	CcSEcCtD
Perflutren—Back pain—Carmustine—malignant glioma	0.00665	0.00694	CcSEcCtD
Perflutren—Erythema—Temozolomide—malignant glioma	0.00664	0.00693	CcSEcCtD
Perflutren—Dysgeusia—Temozolomide—malignant glioma	0.0065	0.00679	CcSEcCtD
Perflutren—Vision blurred—Carmustine—malignant glioma	0.00648	0.00676	CcSEcCtD
Perflutren—Tremor—Carmustine—malignant glioma	0.00644	0.00672	CcSEcCtD
Perflutren—Back pain—Temozolomide—malignant glioma	0.00642	0.00671	CcSEcCtD
Perflutren—Agitation—Carmustine—malignant glioma	0.00631	0.00659	CcSEcCtD
Perflutren—Vision blurred—Temozolomide—malignant glioma	0.00626	0.00653	CcSEcCtD
Perflutren—Tremor—Temozolomide—malignant glioma	0.00622	0.00649	CcSEcCtD
Perflutren—Ill-defined disorder—Temozolomide—malignant glioma	0.00616	0.00643	CcSEcCtD
Perflutren—Leukopenia—Carmustine—malignant glioma	0.00615	0.00642	CcSEcCtD
Perflutren—Agitation—Temozolomide—malignant glioma	0.0061	0.00637	CcSEcCtD
Perflutren—Angioedema—Temozolomide—malignant glioma	0.00607	0.00633	CcSEcCtD
Perflutren—Malaise—Temozolomide—malignant glioma	0.00599	0.00625	CcSEcCtD
Perflutren—Vertigo—Temozolomide—malignant glioma	0.00597	0.00623	CcSEcCtD
Perflutren—Convulsion—Carmustine—malignant glioma	0.00595	0.00621	CcSEcCtD
Perflutren—Leukopenia—Temozolomide—malignant glioma	0.00594	0.0062	CcSEcCtD
Perflutren—Hypertension—Carmustine—malignant glioma	0.00593	0.00619	CcSEcCtD
Perflutren—Palpitations—Temozolomide—malignant glioma	0.00587	0.00613	CcSEcCtD
Perflutren—Myalgia—Carmustine—malignant glioma	0.00585	0.00611	CcSEcCtD
Perflutren—Chest pain—Carmustine—malignant glioma	0.00585	0.00611	CcSEcCtD
Perflutren—Cough—Temozolomide—malignant glioma	0.00579	0.00605	CcSEcCtD
Perflutren—Convulsion—Temozolomide—malignant glioma	0.00575	0.00601	CcSEcCtD
Perflutren—Hypertension—Temozolomide—malignant glioma	0.00573	0.00598	CcSEcCtD
Perflutren—Myalgia—Temozolomide—malignant glioma	0.00565	0.0059	CcSEcCtD
Perflutren—Arthralgia—Temozolomide—malignant glioma	0.00565	0.0059	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00561	0.00586	CcSEcCtD
Perflutren—Oedema—Carmustine—malignant glioma	0.00561	0.00585	CcSEcCtD
Perflutren—Discomfort—Temozolomide—malignant glioma	0.00559	0.00583	CcSEcCtD
Perflutren—Dry mouth—Temozolomide—malignant glioma	0.00553	0.00577	CcSEcCtD
Perflutren—Tachycardia—Carmustine—malignant glioma	0.00547	0.00571	CcSEcCtD
Perflutren—Anaphylactic shock—Temozolomide—malignant glioma	0.00542	0.00566	CcSEcCtD
Perflutren—Oedema—Temozolomide—malignant glioma	0.00542	0.00566	CcSEcCtD
Perflutren—Nervous system disorder—Temozolomide—malignant glioma	0.00531	0.00555	CcSEcCtD
Perflutren—Skin disorder—Temozolomide—malignant glioma	0.00526	0.0055	CcSEcCtD
Perflutren—Hypotension—Carmustine—malignant glioma	0.00524	0.00547	CcSEcCtD
Perflutren—Hyperhidrosis—Temozolomide—malignant glioma	0.00524	0.00547	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00511	0.00533	CcSEcCtD
Perflutren—Paraesthesia—Carmustine—malignant glioma	0.00504	0.00526	CcSEcCtD
Perflutren—Dyspnoea—Carmustine—malignant glioma	0.005	0.00522	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00494	0.00515	CcSEcCtD
Perflutren—Paraesthesia—Temozolomide—malignant glioma	0.00487	0.00508	CcSEcCtD
Perflutren—Gastrointestinal disorder—Carmustine—malignant glioma	0.00484	0.00505	CcSEcCtD
Perflutren—Dyspnoea—Temozolomide—malignant glioma	0.00483	0.00504	CcSEcCtD
Perflutren—Pain—Carmustine—malignant glioma	0.0048	0.00501	CcSEcCtD
Perflutren—Dyspepsia—Temozolomide—malignant glioma	0.00477	0.00498	CcSEcCtD
Perflutren—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00468	0.00488	CcSEcCtD
Perflutren—Fatigue—Temozolomide—malignant glioma	0.00467	0.00488	CcSEcCtD
Perflutren—Pain—Temozolomide—malignant glioma	0.00463	0.00484	CcSEcCtD
Perflutren—Feeling abnormal—Carmustine—malignant glioma	0.00462	0.00482	CcSEcCtD
Perflutren—Gastrointestinal pain—Carmustine—malignant glioma	0.00459	0.00479	CcSEcCtD
Perflutren—Feeling abnormal—Temozolomide—malignant glioma	0.00447	0.00466	CcSEcCtD
Perflutren—Abdominal pain—Carmustine—malignant glioma	0.00443	0.00463	CcSEcCtD
Perflutren—Body temperature increased—Carmustine—malignant glioma	0.00443	0.00463	CcSEcCtD
Perflutren—Gastrointestinal pain—Temozolomide—malignant glioma	0.00443	0.00463	CcSEcCtD
Perflutren—Urticaria—Temozolomide—malignant glioma	0.00431	0.00449	CcSEcCtD
Perflutren—Body temperature increased—Temozolomide—malignant glioma	0.00428	0.00447	CcSEcCtD
Perflutren—Abdominal pain—Temozolomide—malignant glioma	0.00428	0.00447	CcSEcCtD
Perflutren—Hypersensitivity—Carmustine—malignant glioma	0.00413	0.00431	CcSEcCtD
Perflutren—Asthenia—Carmustine—malignant glioma	0.00402	0.0042	CcSEcCtD
Perflutren—Hypersensitivity—Temozolomide—malignant glioma	0.00399	0.00417	CcSEcCtD
Perflutren—Asthenia—Temozolomide—malignant glioma	0.00389	0.00406	CcSEcCtD
Perflutren—Diarrhoea—Carmustine—malignant glioma	0.00384	0.00401	CcSEcCtD
Perflutren—Pruritus—Temozolomide—malignant glioma	0.00383	0.004	CcSEcCtD
Perflutren—Dizziness—Carmustine—malignant glioma	0.00371	0.00387	CcSEcCtD
Perflutren—Diarrhoea—Temozolomide—malignant glioma	0.00371	0.00387	CcSEcCtD
Perflutren—Dizziness—Temozolomide—malignant glioma	0.00358	0.00374	CcSEcCtD
Perflutren—Vomiting—Carmustine—malignant glioma	0.00357	0.00372	CcSEcCtD
Perflutren—Rash—Carmustine—malignant glioma	0.00354	0.00369	CcSEcCtD
Perflutren—Dermatitis—Carmustine—malignant glioma	0.00353	0.00369	CcSEcCtD
Perflutren—Headache—Carmustine—malignant glioma	0.00351	0.00367	CcSEcCtD
Perflutren—Vomiting—Temozolomide—malignant glioma	0.00345	0.0036	CcSEcCtD
Perflutren—Rash—Temozolomide—malignant glioma	0.00342	0.00357	CcSEcCtD
Perflutren—Dermatitis—Temozolomide—malignant glioma	0.00341	0.00356	CcSEcCtD
Perflutren—Headache—Temozolomide—malignant glioma	0.00339	0.00354	CcSEcCtD
Perflutren—Nausea—Carmustine—malignant glioma	0.00333	0.00348	CcSEcCtD
Perflutren—Nausea—Temozolomide—malignant glioma	0.00322	0.00336	CcSEcCtD
